Literature DB >> 15010890

Dietary boron intake and prostate cancer risk.

Yan Cui1, Meiko I Winton, Zuo-Feng Zhang, Charlene Rainey, James Marshall, Jean B De Kernion, Curtis D Eckhert.   

Abstract

Boron affects human steroid hormone levels. Circulating testosterone and estradiol levels have been proposed to modify prostate cancer risk. However, the association between dietary boron intake and the risk of prostate cancer has not been evaluated by any epidemiological study. We explored the association between dietary boron intake and the risk of prostate cancer in the USA. Our analysis was based on data from the third National Health and Nutrition Examination Survey (NHANES III). Cross-sectional case-control study design was employed by comparing boron intake of 95 prostate cancer cases with that of 8,720 male controls. After controlling for age, race, education, smoking, body mass index, dietary caloric intake, and alcohol consumption, increased dietary boron intake was associated with a decreased risk of prostate cancer with a dose-response pattern. The adjusted odds ratio was 0.46 (95% confidence interval: 0.21-0.98) for the highest quartile of boron intake comparing to the lowest quartile (P for trend = 0.0525). The observed association should be interpreted with caution because of the small case sample size and the nature of the cross-sectional study design, but deserve further investigation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15010890

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  15 in total

1.  The major facilitator superfamily transporter Knq1p modulates boron homeostasis in Kluyveromyces lactis.

Authors:  Alexandra Svrbicka; Nora Toth Hervay; Yvetta Gbelska
Journal:  Folia Microbiol (Praha)       Date:  2015-07-05       Impact factor: 2.099

2.  Cytotoxic and Apoptotic Effects of the Combination of Borax (Sodium Tetraborate) and 5-Fluorouracil on DLD-1 Human Colorectal Adenocarcinoma Cell Line.

Authors:  Ömer Faruk Kırlangıç; Ecem Kaya-Sezginer; Sema Ören; Serap Gür; Özlem Yavuz; Taner Özgürtaş
Journal:  Turk J Pharm Sci       Date:  2022-08-31

3.  Antioxidant therapy prevents ethylene glycol-induced renal calcium oxalate crystal deposition in Wistar rats.

Authors:  Mohammad Reza Naghii; Eslam Eskandari; Mahmood Mofid; Mehdi Jafari; Mohammad Hossein Asadi
Journal:  Int Urol Nephrol       Date:  2014-02-20       Impact factor: 2.370

4.  Dietary boron and hormone replacement therapy as risk factors for lung cancer in women.

Authors:  S Mahabir; M R Spitz; S L Barrera; Y Q Dong; C Eastham; M R Forman
Journal:  Am J Epidemiol       Date:  2008-03-14       Impact factor: 4.897

5.  Phenylboronic acid selectively inhibits human prostate and breast cancer cell migration and decreases viability.

Authors:  Tiffany M Bradke; Casey Hall; Stephen W Carper; George E Plopper
Journal:  Cell Adh Migr       Date:  2008-07-23       Impact factor: 3.405

6.  Boron stress activates the general amino acid control mechanism and inhibits protein synthesis.

Authors:  Irem Uluisik; Alaattin Kaya; Dmitri E Fomenko; Huseyin C Karakaya; Bradley A Carlson; Vadim N Gladyshev; Ahmet Koc
Journal:  PLoS One       Date:  2011-11-17       Impact factor: 3.240

7.  Protective Effect of Boric Acid on Oxidative DNA Damage In Chinese Hamster Lung Fibroblast V79 Cell Lines.

Authors:  Sezen Yılmaz; Aylin Ustundag; Ozge Cemiloglu Ulker; Yalcın Duydu
Journal:  Cell J       Date:  2016-01-17       Impact factor: 2.479

8.  Receptor activated Ca(2+) release is inhibited by boric acid in prostate cancer cells.

Authors:  Kimberly Henderson; Salvatore L Stella; Sarah Kobylewski; Curtis D Eckhert
Journal:  PLoS One       Date:  2009-06-23       Impact factor: 3.240

Review 9.  Nothing Boring About Boron.

Authors:  Lara Pizzorno
Journal:  Integr Med (Encinitas)       Date:  2015-08

10.  Cellular changes in boric acid-treated DU-145 prostate cancer cells.

Authors:  W T Barranco; C D Eckhert
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.